APO Research

APO RESEARCH · REPORT

EMOCAP

Selected research

Market Structure

Global EMOCAP Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global EMOCAP market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for EMOCAP is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for EMOCAP is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for EMOCAP is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for EMOCAP is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of EMOCAP include StretchSense, Noitom, Vicon, Cyber Glove Systems, Rokoko, MANUS, AiQ Synertial, Virtual Motion Labs and PhaseSpace, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global EMOCAP market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of EMOCAP and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents EMOCAP revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the EMOCAP market size, projected growth trends, production technologies, key applications, and end-use industries.

EMOCAP Segment by Company

StretchSense

Noitom

Vicon

Cyber Glove Systems

Rokoko

MANUS

AiQ Synertial

Virtual Motion Labs

PhaseSpace

VRTRIX

HaptX

Virdyn

Qualisys AB

Xsens Technologyes

Optitrack

Codamotion

PTI Phoenix Technologies

Noraxon USA

NTT Data

EMOCAP Segment by Type

Whole Boby

Part Boby

EMOCAP Segment by Application

Scientific Research

Entertainment

Medical

Other

EMOCAP Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global EMOCAP market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of EMOCAP and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of EMOCAP.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of EMOCAP in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global EMOCAP industry.

Chapter 3: Detailed analysis of EMOCAP companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, EMOCAPrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global EMOCAP Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Whole Boby Table 3. Key Players of Part Boby Table 4. Global EMOCAP Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Scientific Research Table 6. Key Players of Entertainment Table 7. Key Players of Medical Table 8. Key Players of Other Table 9. Global EMOCAP Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global EMOCAP Market Size by Region (2021-2026) & (US$ Million) Table 11. Global EMOCAP Market Share by Region (2021-2026) Table 12. Global EMOCAP Market Size by Region (2027-2032) & (US$ Million) Table 13. Global EMOCAP Market Share by Region (2027-2032) Table 14. EMOCAP Industry Trends Table 15. EMOCAP Industry Drivers Table 16. EMOCAP Industry Opportunities and Challenges Table 17. EMOCAP Industry Restraints Table 18. Global EMOCAP Revenue by Company (US$ Million) & (2021-2026) Table 19. Global EMOCAP Revenue Market Share by Company (2021-2026) Table 20. Global EMOCAP Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global EMOCAP Key Company Head Office and Area Served Table 22. Global EMOCAP Company, Product Type & Application Table 23. Global EMOCAP Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global EMOCAP by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global EMOCAP Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global EMOCAP Market Size by Type (2021-2026) & (US$ Million) Table 28. Global EMOCAP Market Size by Type (2027-2032) & (US$ Million) Table 29. Global EMOCAP Revenue Market Share by Type (2021-2026) Table 30. Global EMOCAP Revenue Market Share by Type (2027-2032) Table 31. Global EMOCAP Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global EMOCAP Market Size by Application (2021-2026) & (US$ Million) Table 33. Global EMOCAP Market Size by Application (2027-2032) & (US$ Million) Table 34. Global EMOCAP Revenue Market Share by Application (2021-2026) Table 35. Global EMOCAP Revenue Market Share by Application (2027-2032) Table 36. StretchSense Company Information Table 37. StretchSense Business Overview Table 38. StretchSense EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. StretchSense EMOCAP Product Portfolio Table 40. StretchSense Recent Development Table 41. Noitom Company Information Table 42. Noitom Business Overview Table 43. Noitom EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Noitom EMOCAP Product Portfolio Table 45. Noitom Recent Development Table 46. Vicon Company Information Table 47. Vicon Business Overview Table 48. Vicon EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Vicon EMOCAP Product Portfolio Table 50. Vicon Recent Development Table 51. Cyber Glove Systems Company Information Table 52. Cyber Glove Systems Business Overview Table 53. Cyber Glove Systems EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Cyber Glove Systems EMOCAP Product Portfolio Table 55. Cyber Glove Systems Recent Development Table 56. Rokoko Company Information Table 57. Rokoko Business Overview Table 58. Rokoko EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Rokoko EMOCAP Product Portfolio Table 60. Rokoko Recent Development Table 61. MANUS Company Information Table 62. MANUS Business Overview Table 63. MANUS EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. MANUS EMOCAP Product Portfolio Table 65. MANUS Recent Development Table 66. AiQ Synertial Company Information Table 67. AiQ Synertial Business Overview Table 68. AiQ Synertial EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. AiQ Synertial EMOCAP Product Portfolio Table 70. AiQ Synertial Recent Development Table 71. Virtual Motion Labs Company Information Table 72. Virtual Motion Labs Business Overview Table 73. Virtual Motion Labs EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Virtual Motion Labs EMOCAP Product Portfolio Table 75. Virtual Motion Labs Recent Development Table 76. PhaseSpace Company Information Table 77. PhaseSpace Business Overview Table 78. PhaseSpace EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. PhaseSpace EMOCAP Product Portfolio Table 80. PhaseSpace Recent Development Table 81. VRTRIX Company Information Table 82. VRTRIX Business Overview Table 83. VRTRIX EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. VRTRIX EMOCAP Product Portfolio Table 85. VRTRIX Recent Development Table 86. HaptX Company Information Table 87. HaptX Business Overview Table 88. HaptX EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. HaptX EMOCAP Product Portfolio Table 90. HaptX Recent Development Table 91. Virdyn Company Information Table 92. Virdyn Business Overview Table 93. Virdyn EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. Virdyn EMOCAP Product Portfolio Table 95. Virdyn Recent Development Table 96. Qualisys AB Company Information Table 97. Qualisys AB Business Overview Table 98. Qualisys AB EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. Qualisys AB EMOCAP Product Portfolio Table 100. Qualisys AB Recent Development Table 101. Xsens Technologyes Company Information Table 102. Xsens Technologyes Business Overview Table 103. Xsens Technologyes EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026) Table 104. Xsens Technologyes EMOCAP Product Portfolio Table 105. Xsens Technologyes Recent Development Table 106. Optitrack Company Information Table 107. Optitrack Business Overview Table 108. Optitrack EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026) Table 109. Optitrack EMOCAP Product Portfolio Table 110. Optitrack Recent Development Table 111. Codamotion Company Information Table 112. Codamotion Business Overview Table 113. Codamotion EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026) Table 114. Codamotion EMOCAP Product Portfolio Table 115. Codamotion Recent Development Table 116. PTI Phoenix Technologies Company Information Table 117. PTI Phoenix Technologies Business Overview Table 118. PTI Phoenix Technologies EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026) Table 119. PTI Phoenix Technologies EMOCAP Product Portfolio Table 120. PTI Phoenix Technologies Recent Development Table 121. Noraxon USA Company Information Table 122. Noraxon USA Business Overview Table 123. Noraxon USA EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026) Table 124. Noraxon USA EMOCAP Product Portfolio Table 125. Noraxon USA Recent Development Table 126. NTT Data Company Information Table 127. NTT Data Business Overview Table 128. NTT Data EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026) Table 129. NTT Data EMOCAP Product Portfolio Table 130. NTT Data Recent Development Table 131. North America EMOCAP Market Size by Type (2021-2026) & (US$ Million) Table 132. North America EMOCAP Market Size by Type (2027-2032) & (US$ Million) Table 133. North America EMOCAP Market Size by Application (2021-2026) & (US$ Million) Table 134. North America EMOCAP Market Size by Application (2027-2032) & (US$ Million) Table 135. North America EMOCAP Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. North America EMOCAP Market Size by Country (2021-2026) Table 137. North America EMOCAP Market Size by Country (2027-2032) Table 138. Europe EMOCAP Market Size by Type (2021-2026) & (US$ Million) Table 139. Europe EMOCAP Market Size by Type (2027-2032) & (US$ Million) Table 140. Europe EMOCAP Market Size by Application (2021-2026) & (US$ Million) Table 141. Europe EMOCAP Market Size by Application (2027-2032) & (US$ Million) Table 142. Europe EMOCAP Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. Europe EMOCAP Market Size by Country (2021-2026) Table 144. Europe EMOCAP Market Size by Country (2027-2032) Table 145. China EMOCAP Market Size by Type (2021-2026) & (US$ Million) Table 146. China EMOCAP Market Size by Type (2027-2032) & (US$ Million) Table 147. China EMOCAP Market Size by Application (2021-2026) & (US$ Million) Table 148. China EMOCAP Market Size by Application (2027-2032) & (US$ Million) Table 149. Asia EMOCAP Market Size by Type (2021-2026) & (US$ Million) Table 150. Asia EMOCAP Market Size by Type (2027-2032) & (US$ Million) Table 151. Asia EMOCAP Market Size by Application (2021-2026) & (US$ Million) Table 152. Asia EMOCAP Market Size by Application (2027-2032) & (US$ Million) Table 153. Asia EMOCAP Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. Asia EMOCAP Market Size by Country (2021-2026) Table 155. Asia EMOCAP Market Size by Country (2027-2032) Table 156. South America, Middle East & Africa EMOCAP Market Size by Type (2021-2026) & (US$ Million) Table 157. South America, Middle East & Africa EMOCAP Market Size by Type (2027-2032) & (US$ Million) Table 158. South America, Middle East & Africa EMOCAP Market Size by Application (2021-2026) & (US$ Million) Table 159. South America, Middle East & Africa EMOCAP Market Size by Application (2027-2032) & (US$ Million) Table 160. South America, Middle East & Africa EMOCAP Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 161. South America, Middle East & Africa EMOCAP Market Size by Country (2021-2026) Table 162. South America, Middle East & Africa EMOCAP Market Size by Country (2027-2032) Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources Table 166. Primary Sources List of Figures Figure 1. EMOCAP Product Image Figure 2. Global EMOCAP Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global EMOCAP Market Share by Type: 2025 VS 2032 Figure 4. Whole Boby Image Figure 5. Part Boby Image Figure 6. Global EMOCAP Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global EMOCAP Market Share by Application: 2025 VS 2032 Figure 8. Scientific Research Image Figure 9. Entertainment Image Figure 10. Medical Image Figure 11. Other Image Figure 12. Global EMOCAP Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global EMOCAP Market Size (2021-2032) & (US$ Million) Figure 14. Global EMOCAP Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global EMOCAP Market Share by Players in 2025 Figure 17. Global Top 5 and 10 EMOCAP Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global EMOCAP Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global EMOCAP Revenue Market Share by Type (2021-2032) Figure 21. Global EMOCAP Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global EMOCAP Revenue Market Share by Application (2021-2032) Figure 23. North America EMOCAP Market Size (2021-2032) & (US$ Million) Figure 24. North America EMOCAP Market Share by Type (2021-2032) Figure 25. North America EMOCAP Market Share by Application (2021-2032) Figure 26. North America EMOCAP Market Share by Country (2021-2032) Figure 27. United States EMOCAP Market Size (2021-2032) & (US$ Million) Figure 28. Canada EMOCAP Market Size (2021-2032) & (US$ Million) Figure 29. Mexico EMOCAP Market Size (2021-2032) & (US$ Million) Figure 30. Europe EMOCAP Market Size (2021-2032) & (US$ Million) Figure 31. Europe EMOCAP Market Share by Type (2021-2032) Figure 32. Europe EMOCAP Market Share by Application (2021-2032) Figure 33. Europe EMOCAP Market Share by Country (2021-2032) Figure 34. Germany EMOCAP Market Size (2021-2032) & (US$ Million) Figure 35. France EMOCAP Market Size (2021-2032) & (US$ Million) Figure 36. U.K. EMOCAP Market Size (2021-2032) & (US$ Million) Figure 37. Italy EMOCAP Market Size (2021-2032) & (US$ Million) Figure 38. Russia EMOCAP Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries EMOCAP Market Size (2021-2032) & (US$ Million) Figure 40. China EMOCAP Market Size (2021-2032) & (US$ Million) Figure 41. China EMOCAP Market Share by Type (2021-2032) Figure 42. China EMOCAP Market Share by Application (2021-2032) Figure 43. Asia EMOCAP Market Size (2021-2032) & (US$ Million) Figure 44. Asia EMOCAP Market Share by Type (2021-2032) Figure 45. Asia EMOCAP Market Share by Application (2021-2032) Figure 46. Asia EMOCAP Market Share by Country (2021-2032) Figure 47. Japan EMOCAP Market Size (2021-2032) & (US$ Million) Figure 48. South Korea EMOCAP Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan EMOCAP Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia EMOCAP Market Size (2021-2032) & (US$ Million) Figure 51. India EMOCAP Market Size (2021-2032) & (US$ Million) Figure 52. Australia EMOCAP Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa EMOCAP Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa EMOCAP Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa EMOCAP Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa EMOCAP Market Share by Country (2021-2032) Figure 57. Brazil EMOCAP Market Size (2021-2032) & (US$ Million) Figure 58. South Africa EMOCAP Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia EMOCAP Market Size (2021-2032) & (US$ Million) Figure 60. Turkey EMOCAP Market Size (2021-2032) & (US$ Million) Figure 61. Argentina EMOCAP Market Size (2021-2032) & (US$ Million) Figure 62. UAE EMOCAP Market Size (2021-2032) & (US$ Million) Figure 63. Egypt EMOCAP Market Size (2021-2032) & (US$ Million) Figure 64. Chile EMOCAP Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Whole Boby
  • Part Boby
Applications
  • Scientific Research
  • Entertainment
  • Medical
  • Other
Companies covered
  • StretchSense
  • Noitom
  • Vicon
  • Cyber Glove Systems
  • Rokoko
  • MANUS
  • AiQ Synertial
  • Virtual Motion Labs
  • PhaseSpace
  • VRTRIX
  • HaptX
  • Virdyn
  • Qualisys AB
  • Xsens Technologyes
  • Optitrack
  • Codamotion
  • PTI Phoenix Technologies
  • Noraxon USA
  • NTT Data

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global EMOCAP Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Whole Boby
  5. 1.2.3 Part Boby
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global EMOCAP Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Scientific Research
  9. 1.3.3 Entertainment
  10. 1.3.4 Medical
  11. 1.3.5 Other
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global EMOCAP Growth Trends by Region
  14. 1.5.1 Global EMOCAP Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 EMOCAP Market Size by Region (2021-2026)
  16. 1.5.3 EMOCAP Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global EMOCAP Market Dynamics
  1. 2.1 EMOCAP Industry Trends
  2. 2.2 EMOCAP Industry Drivers
  3. 2.3 EMOCAP Industry Opportunities and Challenges
  4. 2.4 EMOCAP Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global EMOCAP Revenue by Company (2021-2026)
  2. 3.2 Global EMOCAP Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global EMOCAP Key Company Head office and Area Served
  4. 3.4 Global EMOCAP Company, Product Type & Application
  5. 3.5 Global EMOCAP Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global EMOCAP Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 EMOCAP Players Market Share by Revenue in 2025
  9. 3.6.3 2025 EMOCAP Tier 1, Tier 2, and Tier 3
4 EMOCAP Market by Type
  1. 4.1 Global EMOCAP Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global EMOCAP Market Size by Type (2021-2032)
  3. 4.3 Global EMOCAP Market Size Share by Type (2021-2032)
5 EMOCAP Market by Application
  1. 5.1 Global EMOCAP Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global EMOCAP Market Size by Application (2021-2032)
  3. 5.3 Global EMOCAP Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 StretchSense
  2. 6.1.1 StretchSense Company Information
  3. 6.1.2 StretchSense Business Overview
  4. 6.1.3 StretchSense EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 StretchSense EMOCAP Product Portfolio
  6. 6.1.5 StretchSense Recent Developments
  7. 6.2 Noitom
  8. 6.2.1 Noitom Company Information
  9. 6.2.2 Noitom Business Overview
  10. 6.2.3 Noitom EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Noitom EMOCAP Product Portfolio
  12. 6.2.5 Noitom Recent Developments
  13. 6.3 Vicon
  14. 6.3.1 Vicon Company Information
  15. 6.3.2 Vicon Business Overview
  16. 6.3.3 Vicon EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Vicon EMOCAP Product Portfolio
  18. 6.3.5 Vicon Recent Developments
  19. 6.4 Cyber Glove Systems
  20. 6.4.1 Cyber Glove Systems Company Information
  21. 6.4.2 Cyber Glove Systems Business Overview
  22. 6.4.3 Cyber Glove Systems EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Cyber Glove Systems EMOCAP Product Portfolio
  24. 6.4.5 Cyber Glove Systems Recent Developments
  25. 6.5 Rokoko
  26. 6.5.1 Rokoko Company Information
  27. 6.5.2 Rokoko Business Overview
  28. 6.5.3 Rokoko EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Rokoko EMOCAP Product Portfolio
  30. 6.5.5 Rokoko Recent Developments
  31. 6.6 MANUS
  32. 6.6.1 MANUS Company Information
  33. 6.6.2 MANUS Business Overview
  34. 6.6.3 MANUS EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 MANUS EMOCAP Product Portfolio
  36. 6.6.5 MANUS Recent Developments
  37. 6.7 AiQ Synertial
  38. 6.7.1 AiQ Synertial Company Information
  39. 6.7.2 AiQ Synertial Business Overview
  40. 6.7.3 AiQ Synertial EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 AiQ Synertial EMOCAP Product Portfolio
  42. 6.7.5 AiQ Synertial Recent Developments
  43. 6.8 Virtual Motion Labs
  44. 6.8.1 Virtual Motion Labs Company Information
  45. 6.8.2 Virtual Motion Labs Business Overview
  46. 6.8.3 Virtual Motion Labs EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Virtual Motion Labs EMOCAP Product Portfolio
  48. 6.8.5 Virtual Motion Labs Recent Developments
  49. 6.9 PhaseSpace
  50. 6.9.1 PhaseSpace Company Information
  51. 6.9.2 PhaseSpace Business Overview
  52. 6.9.3 PhaseSpace EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 PhaseSpace EMOCAP Product Portfolio
  54. 6.9.5 PhaseSpace Recent Developments
  55. 6.10 VRTRIX
  56. 6.10.1 VRTRIX Company Information
  57. 6.10.2 VRTRIX Business Overview
  58. 6.10.3 VRTRIX EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 VRTRIX EMOCAP Product Portfolio
  60. 6.10.5 VRTRIX Recent Developments
  61. 6.11 HaptX
  62. 6.11.1 HaptX Company Information
  63. 6.11.2 HaptX Business Overview
  64. 6.11.3 HaptX EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 HaptX EMOCAP Product Portfolio
  66. 6.11.5 HaptX Recent Developments
  67. 6.12 Virdyn
  68. 6.12.1 Virdyn Company Information
  69. 6.12.2 Virdyn Business Overview
  70. 6.12.3 Virdyn EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Virdyn EMOCAP Product Portfolio
  72. 6.12.5 Virdyn Recent Developments
  73. 6.13 Qualisys AB
  74. 6.13.1 Qualisys AB Company Information
  75. 6.13.2 Qualisys AB Business Overview
  76. 6.13.3 Qualisys AB EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Qualisys AB EMOCAP Product Portfolio
  78. 6.13.5 Qualisys AB Recent Developments
  79. 6.14 Xsens Technologyes
  80. 6.14.1 Xsens Technologyes Company Information
  81. 6.14.2 Xsens Technologyes Business Overview
  82. 6.14.3 Xsens Technologyes EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Xsens Technologyes EMOCAP Product Portfolio
  84. 6.14.5 Xsens Technologyes Recent Developments
  85. 6.15 Optitrack
  86. 6.15.1 Optitrack Company Information
  87. 6.15.2 Optitrack Business Overview
  88. 6.15.3 Optitrack EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Optitrack EMOCAP Product Portfolio
  90. 6.15.5 Optitrack Recent Developments
  91. 6.16 Codamotion
  92. 6.16.1 Codamotion Company Information
  93. 6.16.2 Codamotion Business Overview
  94. 6.16.3 Codamotion EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Codamotion EMOCAP Product Portfolio
  96. 6.16.5 Codamotion Recent Developments
  97. 6.17 PTI Phoenix Technologies
  98. 6.17.1 PTI Phoenix Technologies Company Information
  99. 6.17.2 PTI Phoenix Technologies Business Overview
  100. 6.17.3 PTI Phoenix Technologies EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 PTI Phoenix Technologies EMOCAP Product Portfolio
  102. 6.17.5 PTI Phoenix Technologies Recent Developments
  103. 6.18 Noraxon USA
  104. 6.18.1 Noraxon USA Company Information
  105. 6.18.2 Noraxon USA Business Overview
  106. 6.18.3 Noraxon USA EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Noraxon USA EMOCAP Product Portfolio
  108. 6.18.5 Noraxon USA Recent Developments
  109. 6.19 NTT Data
  110. 6.19.1 NTT Data Company Information
  111. 6.19.2 NTT Data Business Overview
  112. 6.19.3 NTT Data EMOCAP Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 NTT Data EMOCAP Product Portfolio
  114. 6.19.5 NTT Data Recent Developments
7 North America
  1. 7.1 North America EMOCAP Market Size (2021-2032)
  2. 7.2 North America EMOCAP Market Size by Type
  3. 7.2.1 North America EMOCAP Market Size by Type (2021-2026)
  4. 7.2.2 North America EMOCAP Market Size by Type (2027-2032)
  5. 7.2.3 North America EMOCAP Market Share by Type (2021-2032)
  6. 7.3 North America EMOCAP Market Size by Application
  7. 7.3.1 North America EMOCAP Market Size by Application (2021-2026)
  8. 7.3.2 North America EMOCAP Market Size by Application (2027-2032)
  9. 7.3.3 North America EMOCAP Market Share by Application (2021-2032)
  10. 7.4 North America EMOCAP Market Size by Country
  11. 7.4.1 North America EMOCAP Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America EMOCAP Market Size by Country (2021-2026)
  13. 7.4.3 North America EMOCAP Market Size by Country (2027-2032)
  14. 7.4.4 North America EMOCAP Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe EMOCAP Market Size (2021-2032)
  2. 8.2 Europe EMOCAP Market Size by Type
  3. 8.2.1 Europe EMOCAP Market Size by Type (2021-2026)
  4. 8.2.2 Europe EMOCAP Market Size by Type (2027-2032)
  5. 8.2.3 Europe EMOCAP Market Share by Type (2021-2032)
  6. 8.3 Europe EMOCAP Market Size by Application
  7. 8.3.1 Europe EMOCAP Market Size by Application (2021-2026)
  8. 8.3.2 Europe EMOCAP Market Size by Application (2027-2032)
  9. 8.3.3 Europe EMOCAP Market Share by Application (2021-2032)
  10. 8.4 Europe EMOCAP Market Size by Country
  11. 8.4.1 Europe EMOCAP Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe EMOCAP Market Size by Country (2021-2026)
  13. 8.4.3 Europe EMOCAP Market Size by Country (2027-2032)
  14. 8.4.4 Europe EMOCAP Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China EMOCAP Market Size (2021-2032)
  2. 9.2 China EMOCAP Market Size by Type
  3. 9.2.1 China EMOCAP Market Size by Type (2021-2026)
  4. 9.2.2 China EMOCAP Market Size by Type (2027-2032)
  5. 9.2.3 China EMOCAP Market Share by Type (2021-2032)
  6. 9.3 China EMOCAP Market Size by Application
  7. 9.3.1 China EMOCAP Market Size by Application (2021-2026)
  8. 9.3.2 China EMOCAP Market Size by Application (2027-2032)
  9. 9.3.3 China EMOCAP Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia EMOCAP Market Size (2021-2032)
  2. 10.2 Asia EMOCAP Market Size by Type
  3. 10.2.1 Asia EMOCAP Market Size by Type (2021-2026)
  4. 10.2.2 Asia EMOCAP Market Size by Type (2027-2032)
  5. 10.2.3 Asia EMOCAP Market Share by Type (2021-2032)
  6. 10.3 Asia EMOCAP Market Size by Application
  7. 10.3.1 Asia EMOCAP Market Size by Application (2021-2026)
  8. 10.3.2 Asia EMOCAP Market Size by Application (2027-2032)
  9. 10.3.3 Asia EMOCAP Market Share by Application (2021-2032)
  10. 10.4 Asia EMOCAP Market Size by Country
  11. 10.4.1 Asia EMOCAP Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia EMOCAP Market Size by Country (2021-2026)
  13. 10.4.3 Asia EMOCAP Market Size by Country (2027-2032)
  14. 10.4.4 Asia EMOCAP Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa EMOCAP Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa EMOCAP Market Size by Type
  3. 11.2.1 South America, Middle East & Africa EMOCAP Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa EMOCAP Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa EMOCAP Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa EMOCAP Market Size by Application
  7. 11.3.1 South America, Middle East & Africa EMOCAP Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa EMOCAP Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa EMOCAP Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa EMOCAP Market Size by Country
  11. 11.4.1 South America, Middle East & Africa EMOCAP Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa EMOCAP Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa EMOCAP Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa EMOCAP Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research